Case Finding For COPD in Primary Care: A Qualitative Study of The Views of Health Professionals
Case Finding For COPD in Primary Care: A Qualitative Study of The Views of Health Professionals
Case Finding For COPD in Primary Care: A Qualitative Study of The Views of Health Professionals
Shamil Haroon Background: Chronic obstructive pulmonary disease (COPD) is common but largely
Rachel E Jordan underdiagnosed. Case-finding initiatives have been evaluated in primary care, but few studies
David A Fitzmaurice have explored the views of service providers on implementing them in practice.
Peymane Adab Aim: To explore the views of primary health care providers on case finding for COPD.
Methods: A total of 20 semi-structured interviews were conducted from March 2014 to
School of Health and Population
Sciences, University of Birmingham, September 2014 among general practitioners, nurses, and managers from practices partici-
Edgbaston, Birmingham, UK pating in a large COPD case-finding trial based in primary care in the West Midlands, UK.
Participants’ views were sought to explore perceived benefits, harms, barriers, and facilitators
to implementing COPD case finding in practice. Interviews were transcribed and analyzed
using the framework method.
Results: Participants felt that case finding improves patient care but also acknowledged potential
harms to providers (increase in workload) and to patients (overdiagnosis). Insufficient resources,
poor knowledge of COPD, and limited access to diagnostic services were viewed as barriers to
diagnosis, while provision of community respiratory services, including COPD specialist nurses,
and support from secondary care were thought to be facilitators. Participants also expressed a
need for more education on COPD for both patients and clinicians.
Video abstract
Conclusion: Care providers believe that early detection of COPD improves patient care
but also has accompanying harms. Barriers to diagnosing COPD, such as insufficient exper-
tise in primary care and limited access to diagnostic services in the community, should be
explored and addressed. The knowledge and attitudes of the public about COPD and its
symptoms should also be investigated to inform future education and awareness-raising
strategies.
Keywords: chronic obstructive pulmonary disease, primary care, diagnosis, qualitative
research
Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and
Point your SmartPhone at the code above. If you have a
QR code reader the video abstract will appear. Or use: mortality1 and represents a significant cost to health services and society.2 However,
http://youtu.be/Y0R3ENwvoW8 much of the disease burden remains undiagnosed,3 and there has been a policy drive
to identify COPD early through systematic case finding.4 This has been accompanied
by the evaluation of a number of case-finding strategies.5,6 However, there has been a
Correspondence: Peymane Adab;
paucity of research exploring the views of primary care practitioners on these initia-
Rachel E Jordan tives or factors influencing the ability of health services to screen for and diagnose
School of Health and Population Sciences,
COPD.
University of Birmingham, Edgbaston,
Birmingham B15 2TT, UK A study in Tasmania conducted semi-structured interviews and focus groups to
Tel +44 121 414 3777 explore the views of patients with COPD and their general practitioners (GPs) on
Email p.adab@bham.ac.uk;
r.e.jordan@bham.ac.uk factors influencing the diagnosis of COPD.7 This study found that GPs intentionally
submit your manuscript | www.dovepress.com International Journal of COPD 2015:10 1711–1718 1711
Dovepress © 2015 Haroon et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)
http://dx.doi.org/10.2147/COPD.S84247
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on
how to request permission may be found at: http://www.dovepress.com/permissions.php
Haroon et al Dovepress
authors (SH, REJ, and PA) and compared to create an initial lifestyle behaviors (eg, exercise), and improved quality of
coding framework. Coding of all subsequent transcripts was life and disease prognosis by enabling earlier access to care.
performed by the lead investigator and built on this framework. Some also felt that it would be cost saving for health services
A framework matrix was then constructed, tabulating quotes in the long term.
by their associated codes and participant type. Emergent
I guess the main advantage of screening is presumably to
themes were then discussed and finalized by three authors.
pick up the disease early so that … I mean COPD is to some
The analysis was performed using NVivo version 10.
extent preventable and particularly if you treat it early and I
guess the biggest advantage is … you can encourage them
Ethical approval to stop smoking … if we treat it early, treat it effectively
Ethical approval was provided by the Solihull National
then hopefully there’ll be fewer hospital admissions and
Research Ethics Service committee (reference: 11/WM/
therefore reducing the costs. [GP 8]
0403). All identifiable data were held on an encrypted
database. Several potential harms were also highlighted, including
the impact on health services, such as increased workload,
Results resources, and costs, as well as on patients, including the risk
Practice and participant characteristics of overdiagnosis, the implications of diagnostic labeling on
A total of 162 care providers were invited to participate, of insurance costs, and creating anxiety.
which 20 participants (ten GPs, seven practice nurses, and
… it’s just that impact on workload really, whether primary
three practice managers) from 16 practices were interviewed
care would just be overwhelmed if we started screening …
(Tables 2 and 3). Practices had a range of patient list sizes
you could end up labelling people, which can have a huge
with most having 5–10,000 patients and the majority serving
impact, and they are fine. [Nurse 6]
relatively socioeconomically deprived populations. Approxi-
mately one-third of practices had been in the case-finding arm
of the trial, and all practices had been involved in recruiting Diagnostic strategies
patients for a large COPD cohort study (the Birmingham Participants mainly reported that patients were investigated
COPD Study). Most GPs (70%) interviewed were male, and for COPD on an opportunistic basis when consulting the
all practice nurses and managers were female. Participants health services, particularly when presenting with suggestive
had been in practice on average for 13 or more years. symptoms. Others discussed using a more active approach
such as screening at smoking cessation clinics. A wide
Views on case finding range of factors were considered to be important triggers
Participants were generally of the opinion that early detection for considering COPD, such as smoking status and a his-
of COPD was beneficial for both patients and health services. tory of asthma. Participants also highlighted the potential
Several participants felt that early detection improved smok- of clinical information systems to help identify and flag
ing cessation, helped instigate positive changes to other high-risk patients.
If someone has got appropriate symptoms, a smoking his- man-time implication so unless it’s well-resourced it’s not
tory, and a low FEV1 over V6, then we’ll bring them in for going to happen. [GP 6]
formal spirometry … overall I think it’s not an unreasonable
There was also felt to be a significant lack of knowledge
way to triage the people into proper spirometry. I think
and expertise on COPD in primary care. This included poor
the key thing is not to make the diagnosis on the handheld
understanding of spirometry; difficulties distinguishing
stuff. [GP 7]
between COPD, asthma, and COPD–asthma overlap disease;
Most participants felt that the use of electronic risk pre- and underrecognition of the signs of COPD.
diction tools would be useful for identifying patients at high
I suspect as a profession, we’re not very good at picking
risk of undiagnosed COPD and even to help communicate
up early signs of COPD either … Partly because we, again,
risk to patients. Ease of use, provision of technical support,
attribute a lot of their symptoms to their social habits –
integration with existing clinical information systems, and the
smoking, lack of activity, environment. [GP 3]
generation of automated prompts on electronic health records
were seen as important factors for their implementation. Limited access to diagnostic services was also cited
as a barrier, particularly in smaller practices, which often
I think it’s because we (nurses) always like something to
lack provision of in-house spirometry. Challenges to pro-
refer to and we like to use tools, and I think sometimes that
viding spirometry included costs of equipment and train-
helps just to show the patient as well. Because we use a tool
ing, quality assurance, and availability of appropriately
to assess cardiovascular risk … I found it useful, because
trained staff.
it illustrates to them for example if they’re a smoker you
can calculate their risk as a smoker, and then show them if … you can’t refer for spirometry, the only thing we could
you weren’t a smoker it would be this … So that’s a visual possibly do is buddy up with other practices, but not every
thing for them to see. [Nurse 5] practice has a practice nurse available to do spirometry or
has a spirometry machine. [Practice Manager 1]
A number of participants also highlighted the importance
of being able to refer to secondary care, particularly for more However, some participants did comment on the
challenging clinical presentations. One single-handed GP gradual improvement of diagnostic testing for COPD in the
also commented on the need to refer patients to secondary community.
care for medicolegal protection. It’s getting better I think. I think there was a phase where
people were just doing spirometry willy-nilly without
Barriers to case finding for COPD necessarily having the right equipment, the training to use
Limitation of time, finances, and resources were seen it properly. I think there has been a lot of improvement,
as important barriers to implementing case finding and particularly over the last couple of years with the accredi-
diagnosing COPD. Participants felt that primary care ser- tation …. [GP 3]
vices were already stretched to capacity managing patients
Several patient-related factors were also described as
with established COPD and a lack of additional funding
barriers to diagnosing COPD. These included poor atten-
and resources would prohibit the implementation of case
dance in primary care and late presentation with advanced
finding.
disease. Patients were perceived to sometimes try to cope
… just managing the patients who are already on the COPD with symptoms for as long as possible without consulting the
register is a hell of an onerous task anyway so going out health services until suffering an acute exacerbation. Some
and case finding … there’s a cost implication, there’s a felt that patients often underrecognized the significance of
their symptoms or were not always forthcoming about them generally perceived to be low. Participants also discussed the
or their smoking habits. importance of sharing diagnostic services between practices,
which was especially important for smaller practices with
… a lot of patients have symptoms but they just think that’s
limited service capacity.
what they should have because they’re smokers so they
don’t often seek advice. [Nurse 7] … if say a patient was suspected with COPD and I’ve
sent them off for spirometry, we normally send them off
There was also a view that awareness of COPD among the
to a local service where they have this spirometry, and I
general public was low, that patients were more likely to be
guess luckily for us we do have a respiratory consultant
aware of the more severe stages of the disease, and that smok-
reporting the spirometry findings as well which gives us
ers with undiagnosed COPD often have low expectations of
recommendations. [GP 8]
their health. They also felt that communicating information
about COPD was challenging. The importance of educating patients and the public
about COPD, including ethnic minority populations, was
If you said to the average man on the street, “What’s
also discussed. This included communicating the symptoms
COPD?” they wouldn’t even know what it was … when
of COPD, disseminating information at a community level,
you do try to explain it to them, you get people going into
and use of social marketing and mass publicity.
panic mode then because it doesn’t sound very nice …
there’s just not enough educational publicity surrounding it. I think more patient education, more information out there,
[Practice Manager 1] more publicity … I think it’s got to be in the media really
… If you’ve got these sort of symptoms then see your GP,
Cultural barriers were also discussed, which present chal- get it checked … [Practice Manager 1]
lenges to communicating risk as well as making a diagnosis
because of underrecognition of exposures more common
Perceptions of patients’ responses to
in the developing world, such as indoor air pollution from
cooking fuels.
receiving a diagnosis of COPD
Patients’ responses to being diagnosed with COPD were
I think there is a linguistic barrier; increasing numbers of perceived to be quite variable. Most participants felt that
patients are from ethnic minorities and getting them up and patients accepted their diagnosis and worked with their
looking at them, and actually understanding where their clinicians to improve their lifestyle behaviors, particularly
exposure has been …. You get all the little Asian ladies who in relation to smoking. Patients were perceived to sometimes
cooked on open fires indoors and have COPD from that, even be relieved by the diagnosis, since this allows them to
but then they’re not smokers … So I think there’s a lot of attribute a cause to their chronic symptoms.
cultural things going on here. [GP 7]
I’ve not really had any genuine reluctance to accept a diag-
nosis … I think they take on board what they have been told
Facilitators for diagnosing COPD … take on board the fact that by making lifestyle changes,
Training of health professionals was seen as one of the key they can significantly slow the progress of the process they
facilitators for case finding and diagnosing COPD. Particular have started. [GP 4]
importance was attributed to spirometry training and acquir-
However, it was acknowledged that patients were often
ing a diploma in COPD, which several participating nurses
shocked and upset by the diagnosis, particularly if they
had already achieved.
had family members who had severe disease, and also that
… two of our nurses are going to do a spirometry course to there were implications for insurance costs and potentially
become more up-to-date and obviously qualified in doing employment. Some felt that patients were occasionally very
spirometry, then we could offer more access to spirometry reluctant to accept the diagnosis, particularly when they had
and possibly set up a breathing clinic …. [Nurse 4] no wish to give up smoking.
Access to community respiratory services, including I think because it is a big shock, it is a big diagnosis, as I
specialist COPD nurses, and support from secondary care and said it’s got lots of implications with insurance. I think it
community outreach were also seen as important, particularly frightens patients as well because they look at the worst case
since expertise on respiratory medicine in primary care was scenario and associations with oxygen … [GP 2]
2SSRUWXQLVWLFDOO\
3DWLHQWVHOHFWLRQ $FWLYHO\VHHNRXW GLDJQRVHSDWLHQWVZKHQ 5HIHUUDOWRVHFRQGDU\
8VHRIVFUHHQLQJ
JXLGHGE\FOLQLFDO SDWLHQWVZLWK SUHVHQWLQJZLWKUHOHYDQW FDUHRUFRPPXQLW\
DQGGLDJQRVWLFWHVWV
KLVWRU\ XQGLDJQRVHG&23' VLJQVDQGV\PSWRPV UHVSLUDWRU\VHUYLFHV
3RVLWLYH
%HQHILWV 6WUDWHJLHV •$FFHSWGLDJQRVLV
•,PSURYHVPRNLQJFHVVDWLRQDQG •0DNHSRVLWLYHOLIHVW\OHFKRLFHV
RWKHUOLIHVW\OHEHKDYLRUV •6WRSVPRNLQJ
•,PSURYHGLVHDVHSURJQRVLV •5HOLHIIURPXQGHUVWDQGLQJ
•3URYLVLRQRIDSSURSULDWHKHDOWKFDUH FDXVHRIV\PSWRPV
9LHZVRQ 3DWLHQWV¶
FDVHILQGLQJ 'LDJQRVLVRI&23' UHVSRQVH
+DUPV 1HJDWLYH
•5HVRXUFHLPSOLFDWLRQV •6KRFNHGDQGXSVHW
•2YHUGLDJQRVLV •'HQLDO
•&DXVHDQ[LHW\ •1RFKDQJHLQKHDOWKEHKDYLRUV
•,QVXUDQFHFRVWVIRUSDWLHQWV
)DFLOLWDWRUV %DUULHUV
,PSURYHDFFHVVWRGLDJQRVWLF 3DWLHQWV
•(GXFDWLRQDQGWUDLQLQJRI
VHUYLFHV •3RRUDWWHQGDQFH
KHDOWKSURIHVVLRQDOVDERXW 3ULPDU\FDUH
•&RPPXQLW\UHVSLUDWRU\VHUYLFHV •/DWHSUHVHQWDWLRQ
&23'DQGVSLURPHWU\ •/LPLWHGWLPHPRQH\DQGPDQSRZHU
•6SHFLDOLVW&23'QXUVHV •3RRUUHFRJQLWLRQRI
•(GXFDWLRQRIWKHSXEOLF •,QVXIILFLHQWH[SHUWLVH
•6XSSRUWIURPVHFRQGDU\FDUH V\PSWRPV
DERXW&23'DQGLWV •/LPLWHGDFFHVVWRGLDJQRVWLFVHUYLFHV
•6KDULQJGLDJQRVWLFVHUYLFHVLQ •3RRUDZDUHQHVVRI&23'
V\PSWRPV
SULPDU\FDUH
2. Gibson GJ, Loddenkemper R, Sibille Y, et al. Respiratory health and 11. Health and Social Care Information Centre. Quality and Outcomes
disease in Europe: the new European Lung White Book. Eur Respir J. Framework- 2011–2012, England Level: Clinical Domain, Chronic
2013;42(3):559–563. Obstructive Pulmonary Disease Data Tables. England: Health and
3. Buist AS, McBurnie MA, Vollmer WM, et al; BOLD Collaborative Social Care Information Centre; 2013.
Research Group. International variation in the prevalence of COPD 12. Jordan RE, Adab P, Jowett S, et al. TargetCOPD: a pragmatic ran-
(The BOLD Study): a population-based prevalence study. Lancet. domised controlled trial of targeted case finding for COPD versus routine
2007;370:741–750. practice in primary care: protocol. BMC Pulm Med. 2014;14:157.
4. Department of Health. An Outcomes Strategy for People with Chronic 13. Mason M. Sample Size and Saturation in PhD Studies Using Qualitative
Obstructive Pulmonary Disease (COPD) and Asthma in England. Interviews. Oxford: Oxford Brookes University; 2010.
London: Department of Health; 2011. 14. Morse JM. Determining sample size. Qual Health Res. 2000;10:3–5.
5. Dirven JA, Tange HJ, Muris JW, van Haaren KM, Vink G, van 15. Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the frame-
Schayck OC. Early detection of COPD in general practice: patient or work method for the analysis of qualitative data in multi-disciplinary
practice managed? A randomised controlled trial of two strategies in health research. BMC Med Res Methodol. 2013;13:117.
different socioeconomic environments. Prim Care Respir J. 2013;22: 16. Arne M, Emtner M, Janson S, Wilde-Larsson B. COPD patients perspec-
331–337. tives at the time of diagnosis: a qualitative study. Prim Care Respir J.
6. Haroon S, Adab P, Griffin C, Jordan R. Case finding for chronic obstruc- 2007;16:215–221.
tive pulmonary disease in primary care: a pilot randomised controlled 17. Jones RC, Price D, Ryan D, et al; Respiratory Effectiveness Group.
trial. Br J Gen Pract. 2013;63:26–27. Opportunities to diagnose chronic obstructive pulmonary disease in
7. Walters JA, Hansen EC, Walters EH, Wood-Baker R. Under-diagnosis routine care in the UK: a retrospective study of a clinical cohort. Lancet
of chronic obstructive pulmonary disease: a qualitative study in primary Respir Med. 2014;2:267–276.
care. Respir Med. 2008;102:738–743. 18. Metting EI, Riemersma RA, Kocks JH, Piersma-Wichers MG,
8. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood- Sanderman R, van der Molen T. Feasibility and effectiveness of an
Baker R. A mixed methods study to compare models of spirometry asthma/COPD service for primary care: a cross-sectional baseline
delivery in primary care for patients at risk of COPD. Thorax. 2008;63: description and longitudinal results. NPJ Prim Care Respir Med. 2015;25:
408–414. 14101.
9. British Lung Foundation. Invisible Lives: Chronic Obstructive Pulmo- 19. Bonavia M, Averame G, Canonica W, et al. Feasibility and validation of
nary Disease (COPD) – Finding the Missing Millions. London: British telespirometry in general practice: the Italian “Alliance” study. Respir
Lung Foundation; 2007. Med. 2009;103:1732–1737.
10. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy
for the Diagnosis, Management, and Prevention of Chronic Obstructive
Pulmonary Disease. Marburg: Global Initiative for Chronic Obstructive
Lung Disease; 2013.